Stroke Segment to Dominate MEA SPECT Equipment Market during 2021–2028

According to a new market research study on “MEA SPECT Equipment Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Type, Radioisotopes, Application, and End User” is expected to reach US$ 97.65 million by 2028 from US$ 78.35 million in 2021. The market is estimated to grow at a CAGR of 3.2% from 2021 to 2028. The report provides trends prevailing in the MEA SPECT equipment market along with the drivers and restraints pertaining to the market growth. Restructuring the algorithm permits the technology to exhibit conclusive and detailed information is the major factor driving the growth of the MEA SPECT equipment market. However, issues associated with the high price hinder the growth of MEA SPECT equipment market.

The MEA SPECT equipment market has been segmented based on type, radioisotopes, application, end user, and country. Based on type, the MEA SPECT equipment market is segmented into hybrid SPECT and standalone SPECT. The hybrid SPECT segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. Further, hybrid SPECT is bifurcated by SPECT-CT and SPECT-MR. Based on radioisotopes, the MEA SPECT equipment market is segmented into Iodine-123, Technetium-99m, Xenon-133, Thallium-201, Radium-223, Gallium-66, and other radioisotopes. The Technetium-99m segment dominated the market in 2020 and Ga-66 segment is expected to be the fastest growing during the forecast period. Based on application, the MEA SPECT equipment market is segmented into seizures, stroke, stress fractures, infections, tumors, and others. The stroke segment dominated the market in 2020 and tumors is expected to be the fastest growing during the forecast period. Based on end user, the MEA SPECT equipment market is segmented into hospitals, imaging centers, and others. The hospitals dominated the market in 2020 and imaging centers segment is expected to be the fastest growing during the forecast period. Based on country, the MEA SPECT equipment market is classified into Saudi Arabia, South Africa, UAE, and Rest of MEA.

The onset of COVID-19 resulted into lockdown of the countries in March of 2020. There was an abrupt decrease in cardiovascular testing and procedures as non-urgent cases were deferred to reduce risk of transmission to patients and staff. In a worldwide survey performed by the International Atomic Energy Agency (INCAPS COVID), the survey participants reported a 64% decrease in overall cardiovascular testing and a 73% decrease in nuclear stress test volume in April 2020 compared to April 2019.4 Lower income countries such as UAE, Egypt, Kuwait and Saudi Arabia amongst others experienced an even greater decline in cardiovascular testing which was thought due to decreased access to personal protective equipment. Utilization rates of cardiac SPECT fell further than cardiac PET (74 versus 51%) during the initial phases of the pandemic in the concerned region. Decline in the diagnostic testing coupled with increasing incidence of respiratory conditions among patients made the hospitals worry about the situation in the concerned region all the more. The supply chain disruptions were one of the important fact that led to distribution failures in the Middle East and Africa region. However, the neutralization of the situation coupled with advantages associated with SPECT equipment made the healthcare providers to include the concerned imaging modality into their existing health systems and not using any conventional approaches. This was mainly included in their systems so as to scan images who are suffering from lung dysfunctions and cardiovascular diseases that resulted from the pandemic situation. The SPECT equipment exhibited efficient and accurate results and also provides information based on individual patient category. Such factors enabled the global market growth in these developing regions in the recent years and is anticipated to follow a similar trend over the forecast period.

Bracco Imaging S.p.A.; Bruker Corporation; Cardinal Health, Inc; Curium; Lantheus Medical Imaging Inc.; NTP RADIOISOTOPES; and Spectrum Dynamics Medical are among the leading companies in the MEA SPECT Equipment market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, Curium has announced to invest in new jobs at its Noblesville location to expand our footprint and capabilities at our Noblesville facility to provide our customers and patients reliable access to our innovative products.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com